New Growth Strategy for Novartis
When he was named chief executive in February 2010, Joseph Jimenez has had to fill some big shoes, replacing Daniel Vasella who ran Novartis company for 14 years. When he joined the company there were skeptics, but now the Swiss giant aims to transform itself from a pharmaceutical company to become a broader-based health care company over the next five to ten years.